HOME >> BIOLOGY >> NEWS
American Chemical Society's Weekly PressPac -- July 25, 2007

mature mouse muscle cells (top) and its transformation into nerve-like cells (bottom) after treatment with neurodazine. (Courtesy of Injae Shin, Yonsei University, Korea.)

DOWNLOAD PDF
http://pubs.acs.org/cgi-bin/sample.cgi/jacsat/asap/pdf/ja072817z.pdf

DOWNLOAD HTML
http://pubs.acs.org/cgi-bin/sample.cgi/jacsat/asap/html/ja072817z.html

CONTACT:
Injae Shin, Ph.D.
Department of Chemistry
Yonsei University
Seoul, Korea
Phone: +82-2-2123-2631
E-mail: injae@yonsei.ac.kr


ARTICLE #2 FOR IMMEDIATE RELEASE

Oil spill clean-up agents threaten coral reefs
Environmental Science & Technology

In a setback for efforts to protect endangered coral reefs from oil spills, researchers in Israel report that oil dispersants the best tool for treating oil spills in tropical areas are significantly more toxic to coral than the oil they are used to clean up. Their study, which urges caution in the use of these materials, is scheduled for the August 1 issue of ACS Environmental Science & Technology, a semi-monthly journal.

Called the rainforests of the sea, coral reefs are an endangered ecosystem and are disappearing at an alarming rate due to numerous threats, including over-fishing, global warming and pollution, particularly oil spills. Besides hosting a rich diversity of marine organisms, these habitats are also potential sources of life-saving medicines and food for humans. Scientists looking for better ways to protect this important habitat have recently focused on the environmental impact of oil dispersants, detergents used break down oil spills into smaller, less harmful droplets.

In the new report, Sh
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
30-Jul-2007


Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. American Chemical Society meets Aug. 19-23 in Boston
4. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
5. American buffalo slaughter fueled by international trade
6. American Chemical Societys Weekly PressPac -- July 18, 2007
7. American Chemical Societys Weekly PressPac -- July 11, 2007
8. Tips from the Journals of the American Society for Microbiology
9. Wiley extends publishing partnership with the American Institute of Chemical Engineers
10. Highlights from the July 2007 Journal of the American Dietetic Association
11. Scientific American launches innovative new version of magazine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Chemical Society Weekly PressPac July

(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: